Well, there may finally be a replacement for patients with atrial fibrillation who take warfarin (Coumadin).
In late 2010, the FDA approved the drug Dabigatran (Pradaxa) for use in patients with atrial fibrillation.
Dabigatran is an oral direct thrombin inhibitor that has been approved for stroke prevention in patients with A Fib. The drug does not need monitoring like warfarin, and has been deemed to be safer than warfarin.
